Evidence map›Paper›PMID 39370499›Full record

ReviewReviews in endocrine & metabolic disorders2025

Growth hormone - releasing hormone in the immune system.

Agnieszka Siejka, Hanna Lawnicka, Saikat Fakir, Nektarios Barabutis

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Reviews in endocrine & metabolic disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Mention to Prof. Andrew V. Schally.Reviews in endocrine & metabolic disorders · 2025
    Review
  5. GHRH in diabetes and metabolism.Reviews in endocrine & metabolic disorders · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Agnieszka SiejkaDepartment of Clinical Endocrinology, Medical University of Lodz, Lodz, Poland. agnieszka.siejka@umed.lodz.pl.
Hanna LawnickaDepartment of Immunoendocrinology, Medical University of Lodz, Lodz, Poland.
Saikat FakirSchool of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana Monroe, Monroe, LA, 71201, USA.
Nektarios BarabutisSchool of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana Monroe, Monroe, LA, 71201, USA.

Funding

Synthetic Somatostatin Analogs Protect Against Endothelial Barrier DysfunctionR03AI176433 · UNIVERSITY OF LOUISIANA AT MONROE · 2025 to 2025
$73k
NIAID NIH HHS R03 AI176433The National Institute Of Allergy And Infectious Diseases of the National Institutes of Health R03AI176433Uniwersytet Medyczny w Lodzi 503/1-153-06/503-11-001
6 · The paper itself

Abstract

GHRH is a neuropeptide associated with a diverse variety of activities in human physiology and immune responses. The present study reviews the latest information on the involvement of GHRH in the immune system and inflammation, suggesting that GHRH antagonists may deliver a new therapeutic possibility in disorders related to immune system dysfunction and inflammation.

Indexed as

Growth Hormone-Releasing HormoneImmune SystemAnimalsHumansInflammationGrowth Hormone-Releasing HormoneEndotheliumGHRHGHRH antagonistImmune systemInflammation

Identifiers

PMID39370499
PMCPMC11973240

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.